Akèy › Kansè vejik › Missouri

Etid klinik pou Kansè vejik nan Missouri

27 etid pou Kansè vejik ap chèche patisipan nan sit nan Missouri.

Vil nan Missouri

Tèks ofisyèl etid la (Anglè)

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

Washington University School of Medicine in St. Louis, St Louis

Ap rekriteFaz 1

Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06465069

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Mercy Oncology and Hematology - Clayton-Clarkson, Ballwin
Central Care Cancer Center - Bolivar, Bolivar
Cox Cancer Center Branson, Branson
ak 21 plis

Ap rekriteEtid obsèvasyonVolontè an sante akeyi

Laj 40 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT05334069

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

Saint Francis Medical Center, Cape Girardeau
Parkland Health Center - Farmington, Farmington
University of Kansas Cancer Center - Briarcliff, Kansas City
ak 8 plis

Ap rekriteFaz 2

Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06770582

A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)

University of Missouri Health Care ( Site 0126), Columbia

Ap rekriteFaz 2

Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06833073

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Washington University, School of Medicine, St Louis

Ap rekriteFaz 2

Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06172478

Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial

Saint Francis Medical Center, Cape Girardeau

Ap rekriteFaz 2

Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT07061964

Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)

Missouri Cancer Associates, Columbia

Ap rekriteFaz 3

Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07566156

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Saint Francis Medical Center, Cape Girardeau
Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
Siteman Cancer Center at West County Hospital, Creve Coeur
ak 11 plis

Ap rekriteFaz 2

Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT03866382

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

Siteman Cancer Center - St. Peters, City of Saint Peters
Siteman Cancer Center - West County, Creve Coeur
Siteman Cancer Center - North County, Florissant
ak 4 plis

Ap rekriteFaz 1/2

Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07421700

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Oncology Hematology Associates, Springfield
Washington University School of Medicine, St Louis

Ap rekriteFaz 3

Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07218380

Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease

Washington University School of Medicine, St Louis

Ap rekriteFaz 1

Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT06529822

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

Washington University, St Louis

Ap rekriteFaz 1/2

Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT05267626

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

Specialty Clinical Research of St. Louis, St Louis

Ap rekriteFaz 2

Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT06567743

Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women

Washington University School of Medicine, St Louis

Ap rekriteEtid obsèvasyon

Laj 18 a 50 · Fanm · Mizajou Sep 2, 2026 · NCT06904365

The Vanguard Study: Testing a New Way to Screen for Cancer

Saint Luke's Hospital of Kansas City, Kansas City
Washington University School of Medicine, St Louis

Ap rekriteVolontè an sante akeyi

Laj 45 a 75 · Tout sèks · Mizajou Sep 2, 2026 · NCT06995898

Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

Renown Regional Medical Center, St Louis
Specialty Clinic Research of St. Louis, St Louis

Ap rekriteFaz 2

Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT05951179

Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer

Renown Regional Medical Center, St Louis

Ap rekriteFaz 3

Laj 18 ak plis · Tout sèks · Mizajou Aug 21, 2026 · NCT07480356

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

Washington University in St. Louis, St Louis

Ap rekriteFaz 1

Laj 18 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT05614739

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

Central Care Cancer Center - Bolivar, Bolivar
Mercy Cancer Center - Cape Girardeau, Cape Girardeau
Saint Francis Medical Center, Cape Girardeau
ak 19 plis

Ap rekriteFaz 3

Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT07097142

IDOV-Immune for Advanced Solid Tumors

Washington University School of Medicine, St Louis

Ap rekriteFaz 1

Laj 18 ak plis · Tout sèks · Mizajou Aug 5, 2026 · NCT06910657

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

Mosaic Life Care at Saint Joseph - Medical Center, Saint Joseph

Ap rekriteFaz 2

Laj 8 ak plis · Tout sèks · Mizajou Jul 27, 2026 · NCT05503797

An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC

Research Site, Kansas City

Ap rekriteFaz 3

Laj 18 ak plis · Tout sèks · Mizajou Jul 22, 2026 · NCT07720284

Integrated Cancer Repository for Cancer Research

Saint Luke's Cancer Institute, East, Kansas City
Saint Luke's Cancer Institute, Kansas City
Saint Luke's Cancer Institute, Kansas City North, Kansas City
ak 3 plis

Ap rekriteEtid obsèvasyonVolontè an sante akeyi

Laj 19 a 110 · Tout sèks · Mizajou Jun 29, 2026 · NCT02012699

Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)

Mercy Hospital - SPG, Springfield
Mercy Hospital - South, St Louis
Mercy Hospital -STL, St Louis

Ap rekriteEtid obsèvasyon

Laj 18 ak plis · Tout sèks · Mizajou Jun 29, 2026 · NCT07327489

Clinical Evaluation of BCDx for Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer

Washington University, St Louis

Ap rekriteEtid obsèvasyon

Laj 18 ak plis · Tout sèks · Mizajou Apr 23, 2026 · NCT05982561

Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

Washington University, St Louis

Ap rekriteFaz 1/2

Laj 18 ak plis · Tout sèks · Mizajou Feb 18, 2026 · NCT07030257

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Kansas City
Massive Bio SYNERGY-AI site, St Louis

Ap rekriteEtid obsèvasyon

Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.